As of 2025-10-17, the Relative Valuation of Utah Medical Products Inc (UTMD) is 103.62 USD. This relative valuation is based on P/E multiples. With the latest stock price at 60.08 USD, the upside of Utah Medical Products Inc based on Relative Valuation is 72.5%.
The range of the Relative Valuation is 88.55 - 126.01 USD.
| Range | Selected | |
| Trailing P/E multiples | 24.2x - 32.2x | 28.2x |
| Forward P/E multiples | 23.4x - 27.8x | 25.6x |
| Fair Price | 88.55 - 126.01 | 103.62 |
| Upside | 47.4% - 109.7% | 72.5% |
| Date | P/E |
| 2025-10-16 | 15.36 |
| 2025-10-15 | 15.46 |
| 2025-10-14 | 15.38 |
| 2025-10-13 | 15.48 |
| 2025-10-10 | 15.68 |
| 2025-10-09 | 16.09 |
| 2025-10-08 | 16.22 |
| 2025-10-07 | 16.17 |
| 2025-10-06 | 16.04 |
| 2025-10-03 | 16.19 |
| 2025-10-02 | 16.33 |
| 2025-10-01 | 16.29 |
| 2025-09-30 | 16.10 |
| 2025-09-29 | 16.04 |
| 2025-09-26 | 16.06 |
| 2025-09-25 | 15.97 |
| 2025-09-24 | 16.08 |
| 2025-09-23 | 16.11 |
| 2025-09-22 | 16.18 |
| 2025-09-19 | 15.90 |
| 2025-09-18 | 16.22 |
| 2025-09-17 | 15.81 |
| 2025-09-16 | 15.98 |
| 2025-09-15 | 15.98 |
| 2025-09-12 | 15.93 |
| 2025-09-11 | 15.99 |
| 2025-09-10 | 15.54 |
| 2025-09-09 | 16.06 |
| 2025-09-08 | 16.20 |
| 2025-09-05 | 16.21 |
| 2025-09-04 | 16.04 |
| 2025-09-03 | 15.61 |
| 2025-09-02 | 15.72 |
| 2025-08-29 | 15.91 |
| 2025-08-28 | 15.87 |
| 2025-08-27 | 15.63 |
| 2025-08-26 | 15.53 |
| 2025-08-25 | 15.43 |
| 2025-08-22 | 15.58 |
| 2025-08-21 | 14.70 |
| 2025-08-20 | 14.79 |
| 2025-08-19 | 14.93 |
| 2025-08-18 | 14.61 |
| 2025-08-15 | 14.19 |
| 2025-08-14 | 14.54 |
| 2025-08-13 | 15.19 |
| 2025-08-12 | 14.72 |
| 2025-08-11 | 14.38 |
| 2025-08-08 | 14.40 |
| 2025-08-07 | 14.24 |